Whether Renal Pathology Is an Independent Predictor for End-Stage Renal Disease in Diabetic Kidney Disease Patients with Nephrotic Range Proteinuria: A Biopsy-Based Study

被引:1
|
作者
Wang, Tingli [1 ,2 ]
Zhang, Junlin [1 ,2 ]
Wang, Yiting [1 ,2 ]
Zhao, Lijun [1 ,2 ]
Wu, Yucheng [1 ,2 ]
Ren, Honghong [1 ,2 ]
Zou, Yutong [1 ,2 ]
Zhang, Rui [1 ,2 ]
Xu, Huan [3 ]
Chai, Zhonglin [4 ]
Cooper, Mark E. [4 ]
Zhang, Jie [5 ]
Liu, Fang [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, Div Nephrol, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Hosp, Ctr Diabet & Metab Res, Lab Diabetic Kidney Dis, Chengdu 610041, Peoples R China
[3] Sichuan Univ, West China Hosp, Div Pathol, Chengdu 610041, Peoples R China
[4] Monash Univ, Cent Clin Sch, Dept Diabet, Melbourne, Vic 3004, Australia
[5] Minist Hlth, Regenerat Med Res Ctr, Lab Transplant Engn & Immunol, Chengdu 610041, Peoples R China
基金
中国国家自然科学基金;
关键词
diabetic kidney diseases; end-stage renal disease; nephrotic range proteinuria; renal biopsy; NEPHROPATHY; PROGRESSION; ANEMIA; METAANALYSIS; ALBUMINURIA; HEMOGLOBIN; ADULTS; RISK;
D O I
10.3390/jcm12010088
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To investigate whether renal pathology is an independent predictor for end-stage renal disease (ESRD) in diabetic kidney diseases (DKD) with nephrotic range proteinuria. Methods: A total of 199 DKD patients with nephrotic range proteinuria underwent renal biopsy and were divided into an ESRD group and a non-ESRD group. A Kaplan-Meier analysis was used to compare renal survival rate, and univariate and multivariate Cox proportional hazard analyses were used to determine the predictors of the ESRD. Results: The mean age of included patients was 51.49 +/- 9.12 years and 113 patients (56.8%) progressed to ESRD. The median follow-up period was 16 (12-28) months. The glomerular pathology class III is the most common type (54.3%). In the Kaplan-Meier analysis, compared with patients without ESRD, patients with ESRD had a longer duration of diabetes (>= 6 years), lower eGFR (<60 mL/min/1.73 m(2)), lower albumin (<30 g/L), lower hemoglobin (<120 g/L), and a higher grade of glomerular stage (class III + IV vs. class I + II) (p < 0.05). The hemoglobin and e-GFR, but not the histopathological damage, were significantly associated with a higher risk of ESRD in both the univariate and multivariate Cox analyses. Conclusions: In patients with diabetic kidney disease characterized by nephrotic range proteinuria, histopathological damage (glomerular alterations, interstitial fibrosis and tubular atrophy (IFTA), interstitial inflammation, and arteriolar hyalinosis) is not associated with poor renal outcomes, but hemoglobin and e-GFR could predict poor renal outcomes.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Clinical study of kidney transplantation in diabetic patients with end-stage renal disease
    Sato, S
    Babazono, T
    Tomonaga, O
    Nakamura, M
    Hoshino, T
    Sageshima, J
    Tojimbara, T
    Fujita, S
    Nakajima, I
    Fuchinoue, S
    Teraoka, S
    Agishi, T
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (07) : 3097 - 3098
  • [2] QT Prolongation Is an Independent Predictor of Mortality in End-Stage Renal Disease
    Hage, Fadi G.
    de Mattos, Angelo M.
    Khamash, Hasan
    Mehta, Shikha
    Warnock, David
    Iskandrian, Ami E.
    [J]. CLINICAL CARDIOLOGY, 2010, 33 (06) : 361 - 366
  • [3] Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease
    Shinohara, K
    Shoji, T
    Emoto, M
    Tahara, H
    Koyama, H
    Ishimura, E
    Miki, T
    Tabata, T
    Nishizawa, Y
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (07): : 1894 - 1900
  • [4] Competing Risk of Death With End-Stage Renal Disease in Diabetic Kidney Disease
    Jiang, Yue
    Fine, Jason P.
    Mottl, Amy K.
    [J]. ADVANCES IN CHRONIC KIDNEY DISEASE, 2018, 25 (02) : 133 - 140
  • [5] Proteinuria and the risk of developing end-stage renal disease
    Iseki, K
    Ikemiya, Y
    Iseki, C
    Takishita, S
    [J]. KIDNEY INTERNATIONAL, 2003, 63 (04) : 1468 - 1474
  • [6] Cardiac disease in diabetic end-stage renal disease
    R. N. Foley
    B. F. Culleton
    P. S. Parfrey
    J. D. Harriett
    G. M. Kent
    D. C. Murray
    Paul E. Barre
    [J]. Diabetologia, 1997, 40 : 1307 - 1312
  • [7] Cardiac disease in diabetic end-stage renal disease
    Foley, RN
    Culleton, BF
    Parfrey, PS
    Harnett, JD
    Kent, GM
    Murray, DC
    Barre, PE
    [J]. DIABETOLOGIA, 1997, 40 (11) : 1307 - 1312
  • [8] Risk of Progression of Nonalbuminuric Diabetic Kidney Disease to End-Stage Renal Disease: The CRIC Study
    Koye, Digsu N.
    Magliano, Dianna J.
    Reid, Christopher M.
    Shaw, Jonathan E.
    [J]. DIABETES, 2017, 66 : A429 - A429
  • [9] Transjugular liver biopsy in patients with end-stage renal disease
    Ahmad, A
    Hasan, F
    Abdeen, S
    Sheikh, M
    Kodaj, J
    Nampoory, MR
    Johny, KV
    Asker, H
    Siddique, L
    Thalib, L
    Al-Nakib, B
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2004, 15 (03) : 257 - 260
  • [10] Thyroid Pathology in End-Stage Renal Disease Patients on Hemodialysis
    Cotoi, Laura
    Borcan, Florin
    Sporea, Ioan
    Amzar, Daniela
    Schiller, Oana
    Schiller, Adalbert
    Dehelean, Cristina A.
    Pop, Gheorghe Nicusor
    Borlea, Andreea
    Stoian, Dana
    [J]. DIAGNOSTICS, 2020, 10 (04)